Sort by 'listens'
Risk Stratfiied Treatment and Active Surveillance in Prostate Cancer
Should you opt for active surveillance when diagnosed with prostate cancer or Does your PSA test warrant more aggressive therapy instead? Tune in to hear Dr.Matthew Cooperberg’s views on the controversial PSA testing and hear him talk about treatments based…
Improvements in Myeloma Survival with Dr. Parameswaran Hari
You are 7 times more likely to survive three years in Dr. Hari's care than the care of an average facility that reports their data to the National cancer institute'. Discussing 'Improvements in Myeloma Survival' with clinical director of adult…
Will Precision Medicine work for me? Advances and Challenges in Cancer Research
Precision medicine is an emerging approach in cancer treatment and prevention. It is a shift away from a one-size-fits-all approach and requires sharing of information across research settings and community. Precision Medicine's central principle revolves around the ability to identify…
Alzheimer’s or Dementia. What’s the Difference?
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However,…
Nanotechnology in Oncology
What is nanotechnology and how is this field of technology revolutionizing drug delivery and cancer treatment approach? The Director of National Cancer Institute and Nanotechnology Characterization Laboratory Dr. Anil Patri discuss some of the advantages of having nanotechnolgy as an…